Metal-based Anticancer Agents: Targeting Androgen-dependent and Androgen-independent Prostate and COX-positive Pancreatic Cancer Cells by Phenanthrenequinone Semicarbazone and its Metal Complexes
A planar, polycyclic and aromatic hydrocarbon ligand, namely 9,10-phenanthrenequinone semicarbazone, and its transition metal complexes have been synthesized and structurally characterized. The in vitro antiproliferative activity of these compounds against five human cancer cell lines revealed that they were effective against androgen receptor-positive/negative prostate cancer cells as well as COX-positive pancreatic BxPC-3 cancer cell line. The driving force behind such antiproliferative activity seems to be the up-regulated COX expression in these cells, which was amenable for targeting through metal complexation. These structural motifs can, therefore, serve as a starting point for developing novel cytotoxic agents against the growing number of prostate and pancreatic cancers.
Z. Afrasiabi Navan et al., "Metal-based Anticancer Agents: Targeting Androgen-dependent and Androgen-independent Prostate and COX-positive Pancreatic Cancer Cells by Phenanthrenequinone Semicarbazone and its Metal Complexes," Transition Metal Chemistry, vol. 38, no. 6, pp. 665 - 673, Springer Verlag, Sep 2013.
The definitive version is available at https://doi.org/10.1007/s11243-013-9735-3
Keywords and Phrases
9 ,10-Phenanthrenequinone; Androgen-dependent; Anti-cancer agents; Anti-proliferative activities; Human cancer cells; Pancreatic cancers; Phenanthrenequinone; Prostate cancer cells; Cell culture; Cytotoxicity; Diseases; Metal complexes; Transition metal compounds; Urology; Cells
International Standard Serial Number (ISSN)
Article - Journal
© 2013 Springer Verlag, All rights reserved.
01 Sep 2013